Skip to main content

Table 1 Patient characteristics (n = 44)

From: Clinical significance of peripheral blood and tumor tissue lymphocyte subsets in cervical cancer patients

Median age (range), years

47 (23–70)

FIGO stage

 IB1 (%)

15 (34.1%)

 IB2 (%)

8 (18.2%)

 IIA1 (%)

11 (25.0%)

 IIA2 (%)

10 (22.7%)

Histology

 Squamous carcinoma (%)

40 (90.9%)

 Adenocarcinoma (%)

4 (9.1%)

Stromal invasion ≥1/2 depth (%)

31 (70.5%)

Lymph node metastasis (%)

18 (40.9%)

Positive lymphvascular invasion (%)

21 (47.7%)

Median follow up (range), months

41 (2–48)

Disease status at last follow-up

 Alive, no evidence of disease (%)

36 (81.8%)

 Alive, with disease (%)

5 (11.4%)

 Dead with disease (%)

3 (6.8%)

  1. Abbreviations: FIGO International Federation of Gynecology and Obstetrics